相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lung Cancer Pathology Current Concepts
William D. Travis
CLINICS IN CHEST MEDICINE (2020)
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater
Martin Reck et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Mechanisms of resistance to pemetrexed in non-small cell lung cancer
Jiaqi Liang et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2019)
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
L. Paz-Ares et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
Leora Horn et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer
Scott Kopetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin According to Thymidylate Synthase Expression in Nonsquamous Non-Small-Cell Lung Cancer: A Biomarker-Stratified Randomized Phase II Trial
Jong-Mu Sun et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Combining COPD with Clinical, Pathological and Demographic Information Refines Prognosis and Treatment Response Prediction of Non-Small Cell Lung Cancer
Joseph Putila et al.
PLOS ONE (2014)
Expression of thymidylate synthase predicts clinical outcomes of pemetrexed-containing chemotherapy for non-small-cell lung cancer: a systemic review and meta-analysis
Yu Liu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Thymidylate Synthase Expression and Outcome of Patients Receiving Pemetrexed for Advanced Nonsquamous Non-Small-Cell Lung Cancer in a Prospective Blinded Assessment Phase II Clinical Trial
Marianne C. Nicolson et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
The impact of comorbidity on cancer survival: a review
Mette Sogaard et al.
Clinical Epidemiology (2013)
Expression Profiling-Based Subtyping Identifies Novel Non-small Cell Lung Cancer Subgroups and Implicates Putative Resistance to Pemetrexed Therapy
Jun Hou et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Genetic Changes in Squamous Cell Lung Cancer A Review
Rebecca S. Heist et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Anirudh Prahallad et al.
NATURE (2012)
Thymidylate synthase (TS) gene expression in primary lung cancer patients: a large-scale study in Japanese population
F. Tanaka et al.
ANNALS OF ONCOLOGY (2011)
Treatment-by-Histology Interaction Analyses in Three Phase III Trials Show Superiority of Pemetrexed in Nonsquamous Non-small Cell Lung Cancer
Giorgio Scagliotti et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Significance of thymidylate synthase for resistance to pemetrexed in lung cancer
Hiroaki Ozasa et al.
CANCER SCIENCE (2010)
Endpoints in Phase II Trials for Advanced Non-small Cell Lung Cancer
Sumithra J. Mandrekar et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Performance Status and Smoking Status Are Independent Favorable Prognostic Factors for Survival in Non-small Cell Lung Cancer A Comprehensive Analysis of 26,957 Patients with NSCLC
Tomoya Kawaguchi et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study
Tudor Ciuleanu et al.
LANCET (2009)
The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies
Giorgio Scagliotti et al.
ONCOLOGIST (2009)
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
Giorgio Vittorio Scagliotti et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications
Shrikanta Chattopadhyay et al.
MOLECULAR CANCER THERAPEUTICS (2007)
FMOE-MR: Content-driven multi-resolution MPEG-4 fine grained scalable layered video encoding
S. Chattopadhyay et al.
MULTIMEDIA COMPUTING AND NETWORKING 2007 (2007)
Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase
Paolo Ceppi et al.
CANCER (2006)
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy
N Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
分享论文
